ASHA Course Code: Diversity, Equity, and Inclusion in Education, Training, Service Delivery, Public Policy – 7030
Getting diagnostic decisions right for students from diverse backgrounds is one of the most challenging things evaluators do.
Did you know that we’ve identified a number of markers that can help you more accurately diagnose developmental language disorder (DLD) in bilingual populations?
In this presentation, join Dr. Elizabeth Peña from University of California-Irvine as she discusses effective assessment protocols for bilinguals and demonstrates methods to combine information from two languages to make accurate clinical decisions. In addition, acknowledging the lack of bilingual instruments and bilingual clinicians, we will focus on the English portion of the bilingual DLD profile and its important contribution in the assessment process.
Level, Authors, and Disclosures
Financial Disclosure: Elizabeth Pena, Ph.D., CCC-SLP received an honorarium from Bilinguistics for her presentation.
Non-Financial Disclosure: Elizabeth Pena does not have any non-financial relationships to disclose.
Diagnosing developmental language disorder (DLD) in bilingual populations is challenging. In this webinar, we reviewed markers of DLD for bilinguals and demonstrated methods to combine information from two languages to make accurate clinical decisions. We acknowledged the shortage of bilingual Speech-Language Pathologists. We discussed the impact that the English portion of the testing plays in diagnostic decisions.
Identify markers of impairment appropriate for identification of DLD in Spanish and English.
Combine assessment data from L1 and L2 for accurate diagnostic decisions.
Profile bilingual children’s language performance relative to their English exposure.
05 mins Introduction and overview 20 mins Markers of DLD in bilingual Spanish‐English speakers, implications for test development 15 mins Combining test data from two languages to improve diagnostic decisions 20 mins DLD profile in English 30 mins Moderated Q&A with Dr. Ellen Kester